| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |